Corsano Health to launch CardioWatch 287-2 at MEDICA

Corsano Health is launching the company’s second-generation wearable device that accurately...

Image credit: Corsano Health

Corsano Health is launching the company’s second-generation wearable device that accurately measures eight vital parameters and makes raw PPG and ACC data available for further analysis by third-party medical algorithm developers.

THE HAGUE, THE NETHERLANDS, October 20, 2022 -- Today, Corsano Health, a leading MedTech company developing, producing, and marketing medical grade continuous health monitoring announced the launch of its CardioWatch 287 at MEDICA 2022, Booth 12D33.

MEDICA is the world‘s largest medical marketplace annually organized in Düsseldorf, taking place this year from 14 – 17 November.

Corsano’s CardioWatch 287 accuracy of a state-of-the-art bracelet has been validated in eight third-party clinical investigations. “The independent validations of Corsano Health’s CardioWatch 287 is important evidence to prove accurate measurement of five vital parameters. Moreover, Corsano offers access to raw PPG and ACC data for further analysis to academic researchers and contract research organizations. Corsano’s non-invasive ergonomic wearables deliver medically validate data with superior patient compliance.” said Drs. Peter Stas, CEO of Corsano Health. "Additionally, patient satisfaction surveys conducted at the closure of the studies cite convenience and ease to use of the CardioWatch 287 devices.”

Due to their non-intrusive and convenient nature, wearable devices like Corsano’s CardioWatch 287 have great potential for high volume accessible long-term monitoring of at-risk patients.

About Corsano Health

Corsano Health, based in The Netherlands with offices in Switzerland, is a leading wearable MedTech company developing, producing and marketing medical smart monitoring devices designed to measure vital parameters 24/7 using wireless, non-invasive, and medical-grade technology. The Corsano brand name is derived from in corpore sano (in a healthy body). Corsano’s CardioWatch 287 is a cardiac arrhythmia screening system that provides a simple and effective method for continuous monitoring of vital parameter measurements (i.e., Heart Rate, RR Intervals, Respiration Rate, SpO2, Sleep, Activity, ECG, BIOZ, Core Body Temperature, Cuffless Blood Pressure). More information at http://www.corsano.com

Jürgen Thalmayer
October 24, 2022

Innovation of the month

Do you want to discover more, visit the website
Vist webiste

Other news

Garmin-Lumen Partnership Launches Second Phase Integration With Metabolic Fitness Data

Lumen, the maker of metabolism measurement device through the breath, and Garmin International...

Wearables Of Tomorrow Will Be Your Tool For Personalized Diagnostics

Researchers at Imperial College London and the University of Freiburg have proposed that wearable...

Hyundai Mobis Develops Brainwaves Based ADAS technology To Prevent Drowsy Driving

South Korean automotive supplier Hyundai Mobis has developed M.Brain, a brainwave detection ...

Cyberlink, Tevano, Tiger Tech Implement Biometric Wearables to Prevent COVID-19 Spread

CyberLink has introduced biometric technologies for the prevention of COVID-19 spread with an...
Discover more